In a filing, Thermo Fisher Scientific Inc revealed its Executive Vice President Pettiti Gianluca unloaded Company’s shares for reported $0.13 million on Apr 28 ’25. In the deal valued at $429.93 per share,300 shares were sold. As a result of this transaction, Pettiti Gianluca now holds 23,167 shares worth roughly $9.34 million.
Then, Pettiti Gianluca bought 300 shares, generating $128,979 in total proceeds.
Before that, Boxer Michael A sold 3,775 shares. Thermo Fisher Scientific Inc shares valued at $2,010,537 were divested by the SVP and General Counsel at a price of $532.52 per share. As a result of the transaction, Boxer Michael A now holds 10,816 shares, worth roughly $4.36 million.
Bernstein upgraded its Thermo Fisher Scientific Inc [TMO] rating to an Outperform from a a Mkt perform in a research note published recently. A number of analysts have revised their coverage, including Scotiabank’s analysts, who began to cover the stock in late December with a ‘”a Sector perform”‘ rating. Redburn Atlantic began covering TMO with “Buy” recommendation on October 14, 2024. Stephens started covering the stock on October 01, 2024. It rated TMO as “an Overweight”.
Price Performance Review of TMO
On Friday, Thermo Fisher Scientific Inc [NYSE:TMO] saw its stock fall -1.86% to $403.13. Over the last five days, the stock has lost -4.82%. Thermo Fisher Scientific Inc shares have fallen nearly -22.51% since the year began. Nevertheless, the stocks have fallen -29.63% over the past one year. While a 52-week high of $627.88 was reached on 01/30/25, a 52-week low of $402.81 was recorded on 05/09/25. SMA at 50 days reached $470.26, while 200 days put it at $545.07.
Levels Of Support And Resistance For TMO Stock
The 24-hour chart illustrates a support level at 399.09, which if violated will result in even more drops to 395.05. On the upside, there is a resistance level at 409.83. A further resistance level may holdings at 416.53. The Relative Strength Index (RSI) on the 14-day chart is 31.89, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -13.43, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 97.69%. Stochastics %K at 7.20% indicates the stock is a buying.
The most recent change occurred on August 28, 2024 when Wells Fargo began covering the stock and recommended ‘”an Overweight”‘ rating along with a $670 price target.
